Loading…

Browse All Grants

99,167 grants found

Filters
Reset

Showing 97,52197,540 of 99,167 grants

Completed NON-SBIR/STTR RPGS
High-flow microfluidics of leukapheresis blood products for functional analysis of breast circulating tumor cells
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2021 – 2025

Liquid biopsies are poised to revolutionize cancer therapies, by enabling frequent blood-based monitoring of tumor-derived materials, as cancers evolve in response to therapeutic i...

$6.35M
USD
Completed NON-SBIR/STTR RPGS
A microbiome-dependent bile acid metabolite improves type 2 diabetes.
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND K... Brigham and Women'S Hospital United States 2021 – 2025

Project Summary/Abstract The molecular mechanisms that explain the potent anti-diabetic effects of bariatric surgery remain elusive. The rapid nature of type 2 diabetes mellitus (T...

$551.2K
USD
Completed NON-SBIR/STTR RPGS
Impact of ALS-linked mutations on the structure, dynamics and function of profilin-1
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES University of Massachusetts Med Sch Worc... United States 2021 – 2024

MASSI/ BOSCO – ABSTRACT Profilin-1 (PFN1) is a 15kDa actin-binding protein that plays a critical role in regulating cytoskeletal dynamics. In order to promote actin polymerization...

$5.21M
USD
Completed NON-SBIR/STTR RPGS
A K63-Ubiquitination Dependent Necroptosis Signaling Network in the Heart
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE University of Washington United States 2021 – 2025

Project Summary/Abstract Loss of cardiomyocytes by apoptosis and/or necrosis is a hallmark of cardiac ischemic injury, pathological remodeling, and end-stage heart failure. Althoug...

$3.89M
USD
Completed NON-SBIR/STTR RPGS
Novel Role of Interleukin-17 in Sympathetic Activation in Heart Failure
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE University of Iowa United States 2021 – 2025

Heart failure (HF) is the most common reason for hospitalization and death among those older than 65-years, and statistic is projected to grow as our population ages. The socioecon...

$5.78M
USD
Completed NON-SBIR/STTR RPGS
Intratumor co-delivery of DNA and RNA to relieve cancer pain
NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEAR... New York University United States 2021 – 2025

Oral cancer causes more prevalent and severe pain than any other cancer. Oral cancer patients suffer from severe, chronic, mechanically-induced pain; talking and eating are profoun...

$5.68M
USD
Completed NON-SBIR/STTR RPGS
A Glucocorticoid Receptor-SETDB2 Co-Regulated Liver Metabolic Gene Program
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND K... Johns Hopkins University United States 2021 – 2024

Excess glucocorticoids contribute to the development of diabetes and metabolic syndrome, which includes: obesity, hyperglycemia, hypercholesterolemia, insulin resistance, and liver...

$4.99M
USD
Completed NON-SBIR/STTR RPGS
A microbiome-dependent bile acid metabolite improves type 2 diabetes.
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND K... Brigham and Women'S Hospital United States 2021 – 2025

Project Summary/Abstract The molecular mechanisms that explain the potent anti-diabetic effects of bariatric surgery remain elusive. The rapid nature of type 2 diabetes mellitus (T...

$6.29M
USD
Completed NON-SBIR/STTR RPGS
High-flow microfluidics of leukapheresis blood products for functional analysis of breast circulating tumor cells
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2021 – 2025

Liquid biopsies are poised to revolutionize cancer therapies, by enabling frequent blood-based monitoring of tumor-derived materials, as cancers evolve in response to therapeutic i...

$6.15M
USD
Completed NON-SBIR/STTR RPGS
Impacts of transcription elongation on cardiac gene regulation during homeostasis and regeneration
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE University of California Los Angeles United States 2021 – 2024

Project Summary Heart failure is a major cause of death in the US, contributing significantly to the burden of the healthcare system every year.Despite the heterogeneity of the cau...

$3.9M
USD
Completed NON-SBIR/STTR RPGS
Primary Aldosteronism Subtypes: Pathophysiology and Steroid Signatures
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE University of Michigan At Ann Arbor United States 2021 – 2025

ABSTRACT Primary aldosteronism (PA) is the most common adrenal disorder and the most common cause of endocrine hypertension.PA is associated with cardiovascular morbidity and morta...

$7.52M
USD
Completed NON-SBIR/STTR RPGS
Functional roles of lymphatics in organogenesis and tissue repair
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE Northwestern University At Chicago United States 2021 – 2024

SUMMARY Work performed during the last decade revealed the first molecular insights into lymphatic vascular biology. Some of those findings build the foundation for the studies to...

$6.88M
USD
Completed NON-SBIR/STTR RPGS
Understanding and manipulating programmed cell death (PCD) pathways to facilitate lymphoid tumor killing by CAR T cells
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2021 – 2025

PROJECT SUMMARY Recent advances using CAR T cells in lymphoid malignancies have made it clear that manipulation of the host immune system can radically alter the course of a cancer...

$7.2M
USD
Completed NON-SBIR/STTR RPGS
Investigating multifactorial beta-catenin activation in hepatocellular cancers
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2025

Abstract Hepatocellular carcinoma (HCC) is a deadly malignancy with limited treatment options, and lacks molecular- targeted therapies. Activation of Wnt/?-catenin cascade has been...

$5.12M
USD
Completed NON-SBIR/STTR RPGS
Novel Vector Platform for Gene Therapy
NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOEN... Washington University United States 2021 – 2023

ABSTRACT Inherited serum deficiency disorders, such as hemophilia and ?1-antitrypsin (AAT) deficiency, have been considered ideal candidates for corrective gene therapy.In this reg...

$4.22M
USD
Completed NON-SBIR/STTR RPGS
Successful Clinical Response In Pneumonia Therapy (SCRIPT) Systems Biology Center
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Northwestern University At Chicago United States 2021 – 2022

Modified Project Summary/Abstract Section This innovative integrated systems biology application seeks to delineate the complex host/pathogen interactions occurring at the alveolar...

$1.2M
USD
Completed NON-SBIR/STTR RPGS
Impacts of transcription elongation on cardiac gene regulation during homeostasis and regeneration
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE University of California Los Angeles United States 2021 – 2024

Project Summary Heart failure is a major cause of death in the US, contributing significantly to the burden of the healthcare system every year. Despite the heterogeneity of the ca...

$3.9M
USD
Completed NON-SBIR/STTR RPGS
Primary Aldosteronism Subtypes: Pathophysiology and Steroid Signatures
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE University of Michigan At Ann Arbor United States 2021 – 2025

ABSTRACT Primary aldosteronism (PA) is the most common adrenal disorder and the most common cause of endocrine hypertension. PA is associated with cardiovascular morbidity and mort...

$7.02M
USD
Completed NON-SBIR/STTR RPGS
Functional roles of lymphatics in organogenesis and tissue repair
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE Northwestern University At Chicago United States 2021 – 2024

SUMMARY Work performed during the last decade revealed the first molecular insights into lymphatic vascular biology. Some of those findings build the foundation for the studies to...

$6.23M
USD
Completed NON-SBIR/STTR RPGS
Understanding and manipulating programmed cell death (PCD) pathways to facilitate lymphoid tumor killing by CAR T cells
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2021 – 2025

PROJECT SUMMARY Recent advances using CAR T cells in lymphoid malignancies have made it clear that manipulation of the host immune system can radically alter the course of a cancer...

$6.89M
USD